Cookeville, TN – The U.S. Food and Drug Administration (FDA) issued a recommendation to health care providers last week that additional patient notification should take place related to the fungal meningitis outbreak connected to injectable products from the New England Compounding Center (NECC).

Yesterday the Tennessee Department of Health released a list of Tennessee facilities who had received products from the New England Compounding Center (NECC).

The list released yesterday did not differentiate between which facilities received the injectable medications and which ones did not.  Although Cookeville Regional Medical Center was on the list, it has not received nor used any of the injectable medications from NECC associated with the fungal meningitis outbreak.

Today the U.S. Food and Drug Administration (FDA) has stated some technical problems and incorrect data in the list of facilities released yesterday.  That list has also been pulled from the Tennessee Department of Health’s website until they have a more accurate list of facilities who received the injectable medications from NECC.  Again, Cookeville Regional has not received any injectable medications from NECC.

Cookeville Regional received only one medication from the NECC, and it was a topical cream that is used only on the skin.  It is no longer in use. As a precautionary measure, the FDA has recalled all NECC products.